BioSpace News Archive

Biotech Beach

Genomic Testing Cooperative Completes New York State Approval and Medicare (Palmetto) Coverage for all DNA and RNA Tests Offered for Molecular Profiling of Hematologic and Solid Tumors

Genomic Testing Cooperative, LCA announced that the New York State Clinical Evaluation Program has completed their evaluation and approved all GTC’s Next Generation Sequencing profiling tests for hematologic neoplasms and solid tumors.

June 23, 2021
·
3 min read
Promega 2021 Corporate Responsibility Report Sets 2030 Sustainability Targets, Spotlights COVID-19 Response

Promega Corporation. The 2021 Corporate Responsibility Report, released today, features new 2030 Environmental Improvement Goals alongside stories of how Promega is supporting researchers, employees and communities during the COVID-19 pandemic.

June 23, 2021
·
4 min read
Drug Development

Clovis Oncology Announces LuMIERE Clinical Trial Evaluating Novel Peptide-Targeted Radionuclide Therapy FAP-2286 Now Open for Enrollment

Clovis Oncology, Inc. announced today that the first clinical site for the Phase 1/2 LuMIERE study of FAP-2286.

June 23, 2021
·
8 min read
Genetown

ImmuneID Announces Close of $50 Million Series A Financing to Develop Precision Immunology Therapeutics

ImmuneID, Inc. today announced that it has raised $50 million in Series A financing.

June 23, 2021
·
3 min read
Business

Abata Therapeutics Launches to Usher in New Era of Cell Therapy Using Targeted Regulatory T Cells to Treat Serious Autoimmune and Inflammatory Diseases

Third Rock Ventures today announced the launch of Abata Therapeutics.

June 23, 2021
·
8 min read
Drug Development

Gamida Cell Announces Publication in Blood, the Journal of the American Society of Hematology, of the First Pivotal Trial to Evaluate a Cell Therapy (Omidubicel)

Gamida Cell Announces Publication in Blood , the Journal of the American Society of Hematology, of the First Pivotal Trial to Evaluate a Cell Therapy (Omidubicel) for Patients with Blood Cancer who Require an Allogeneic Stem Cell Transplant

June 23, 2021
·
8 min read
Xenter, Inc. Purchases RORγT Clinical Program; Launches Xenter Therapeutics Business Unit Led by David J. Bearss, PhD

- Xenter Therapeutics Joins Xenter Hospital Technologies as New Business Unit to Advance Device/Data/Drug Technologies for Interventional Medicine, Pharmaceutical Advancements and Digital Health -

June 23, 2021
·
4 min read
Mydecine to Participate in the ROTH Virtual Healthcare Private Company Forum on June 28th

Mydecine Innovations Group today announced that Josh Bartch, CEO of Mydecine, will participate in the ROTH Healthcare Private Company Forum to be hosted virtually on Monday, June 28, 2021.

June 23, 2021
·
4 min read
Inotrem Adds a New Strategic Asset to Its Immunotherapy Anti-TREM-1 Drug Pipeline

Inotrem, an advanced clinical stage biotech company specialized in immunotherapies for acute and chronic inflammatory syndromes, announced that it has filed a patent to protect a new therapeutic modality against TREM-1, a monoclonal antibody.

June 23, 2021
·
3 min read
Policy

Amgen Announces Approval Of Aimovig® (Erenumab) In Japan For The Suppression Of Onset Of Migraine Attacks In Adults

Amgen announced that the Japanese Ministry of Health, Labour and Welfare has granted marketing approval for Aimovig® for the suppression of onset of migraine attacks in adults.

June 23, 2021
·
20 min read